Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled and Double-blinded Clinical Trial to Investigate the Efficacy and Safety of BEJO Red Ginger as an Adjuvant Therapy in COVID-19 Hospitalized Patients With Mild Symptoms

NCT05277155 is registered in ClinicalTrials.gov with Research Center for Chemistry, National Research and Innovation Agency of Indonesia as lead sponsor.

NCT NCT05277155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled and Double-blinded Clinical Trial to Investigate the Efficacy and Safety of BEJO Red Ginger as an Adjuvant Therapy in COVID-19 Hospitalized Patients With Mild Symptoms
Lead sponsor
Research Center for Chemistry, National Research and Innovation Agency of Indonesia
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 22, 2022
Completion date
August 22, 2022
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19